dc.contributor.author | RADOMSKI, MAREK | |
dc.date.accessioned | 2012-06-27T09:22:23Z | |
dc.date.available | 2012-06-27T09:22:23Z | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011 | en |
dc.identifier.citation | Cockburn, A., Bradford, R., Buck, N., Constable, A., Edwards, G., Haber, B.,Hepburn, P., Howlett, J., Kampers, F., Klein, C., Radomski, M., Stamm, H., Wijnhoven, S., Wildemann, T., Approaches to the safety assessment of engineered nanomaterials (ENM) in food, Food and Chemical Toxicology, Volume 50, Issue 6, June 2012, Pages 2224-2242 | en |
dc.identifier.other | Y | |
dc.description | PUBLISHED | en |
dc.description.abstract | A systematic, tiered approach to assess the safety of engineered nanomaterials (ENMs) in foods is presented. The ENM is first compared to its non-nano form counterpart to determine if ENM-specific assessment is required. Of highest concern from a toxicological perspective are ENMs which have potential for systemic translocation, are insoluble or only partially soluble over time or are particulate and bio- persistent. Where ENM-specific assessment is triggered, Tier 1 screening considers the potential for translocation across biological barriers, cytotoxicity, generation of reactive oxygen species, inflammatory response, genotoxicity and general toxicity. In silico and in vitro studies, together with a sub-acute repeat-dose rodent study,could be considered for this phase. Tier 2 hazard characterisation is based on a sentinel 90-day rodent study with an extended range of endpoints, additional parameters being investigated case-by-case. Physicochemical characterisation should be performed in a range of food and biological matrices. A default assumption of 100% bioavailability of the ENM provides a `worst case? exposure scenario, which could be refined as additional data become available. The safety testing strategy is considered applicable to variations in ENM size within the nanoscale and to new generations of ENM. | en |
dc.description.sponsorship | This work was commissioned by the Novel Foods and Nanotechnology Task Force of the European Branch of the International Life Sciences Institute (ILSI Europe). Industry members of this task force are BASF, Coca-Cola Europe, Danone, DSM, Kraft Foods Europe, Mars, Nestle and Unilever. This publication was coordinated by Tanja Wildemann, Scientific Project Manager at ILSI Europe. For further information about ILSI Europe, please email info@ilsieurope.be or call +32 2 771 00 14. The opinions expressed herein and the conclusions of this publication are those of the authors and do not necessarily represent the views of ILSI Europe nor those of the supporting companies. | en |
dc.language.iso | en | en |
dc.publisher | Elsevier | en |
dc.relation.ispartofseries | Food and Chemical Toxicology;50, 6 | |
dc.relation.ispartofseries | 2011 Dec 29. [Epub]; | |
dc.rights | Y | en |
dc.subject | Nanomaterials | en |
dc.subject | engineered nanomaterials (ENMs) | en |
dc.subject | food | en |
dc.subject | risk assessment | en |
dc.title | Approaches to the safety assessment of engineered nanomaterials (ENM) in food | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/radomskm | |
dc.identifier.rssinternalid | 76503 | |
dc.identifier.uri | http://hdl.handle.net/2262/64030 | |